INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Scaling For Success: Preparing Your Cell Culture Workflow

  Uncover how early planning of medium, feed systems, and manufacturing workflow can mitigate costs, reduce delays, and accelerate therapeutic delivery to patients.

• Food Safety Digital Maturity In The Supply Chain

  Look at how connected data and automated processes strengthen safety, improve traceability, and streamline compliance across the supply chain—offering a clear roadmap for progression.

• Demonstrating Technical Excellence In Contract Manufacturing

  Tech Talks explore ADC development innovations, including integrated supply chains, seamless pilot-to-GMP scale-ups, and advanced process analytical technology (PAT).

• Quality Roundtable: Raw Material Planning For Tech Transfer And Scaling Biologics

  Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.

• Optimizing End-To-End Contract Analytical Support For Cell And Gene Therapies

  7/11/2024

  The development and production of CGTs presents unparalleled complexities. Learn how a partner with robust end-to-end services can help you overcome challenges at every step of the drug lifecycle.

• Accelerating Cold Chain Expansion: Responding To COVID-19 Challenges

  8/21/2024

  Review how leveraging cross-functional teamwork helped complete a cold chain infrastructure expansion in a fraction of the expected timeline, ensuring the production of essential COVID-19 therapeutics.

• Empowering Patients With Self-Administration Drug Delivery Devices

  8/16/2025

  Discover how these devices offer solutions to the challenges of precise dosing, patient compliance, retention, and safety, uplifting the overall trial experience and providing real world insights.

• A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications

  6/9/2025

  Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

• Risk Mitigation For Late-Stage Clinical Assets

  6/11/2025

  Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.